ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,039.31
      -0.47%
      US Tech 100
      20,882.00
      0.05%
      Dow Jones
      44,713.52
      -0.31%
      Brent Oil
      75.575
      -0.45%
      Bitcoin
      105,314.18
      1.52%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Spyre Therapeutics Inc (SYRE) Quote

      Spyre Therapeutics Inc

      Spyre Therapeutics Inc (SYRE)

      NASDAQ
      21.90
      0.11
      (0.50%)
      Closed January 30 4:00PM
      Delayed by 15 minutes
      21.90
      0.01
      (0.05%)
      After Hours: 5:00PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      21.90
      Bid
      20.72
      Ask
      23.00
      Volume
      330,139
      21.35 Day's Range 22.18
      20.07 52 Week Range 47.97
      Market Cap
      1.126B
      Previous Close
      21.79
      Open
      21.66
      Last Trade
      1
      @
      21.81
      Last Trade Time
      Financial Volume
      $ 7,220,388
      VWAP
      21.8708
      Average Volume (3m)
      617,266
      Shares Outstanding
      51,431,220
      Dividend Yield
      -
      PE Ratio
      -3.32
      Earnings Per Share (EPS)
      -6.59
      Revenue
      886k
      Net Profit
      -338.79M

      About Spyre Therapeutics Inc

      Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an e... Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.spyre.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Spyre Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SYRE. The last closing price for Spyre Therapeutics was $21.79. Over the last year, Spyre Therapeutics shares have traded in a share price range of $ 20.07 to $ 47.97.

      Spyre Therapeutics currently has 51,431,220 shares outstanding. The market capitalization of Spyre Therapeutics is $1.12 billion. Spyre Therapeutics has a price to earnings ratio (PE ratio) of -3.32.

      Ask ADVFN Intelligence (AI)

      SYRE Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities

      January 17 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 17 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 17 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 17 2025
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      January 14 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      January 13 2025
      Edgar (US Regulatory)

      Spyre Therapeutics Highlights 2025 Priorities and Robust Pipeline of Upcoming Clinical Readouts

      Spyre Therapeutics Highlights 2025 Priorities and Robust Pipeline of Upcoming Clinical Readouts PR Newswire WALTHAM, Mass., Jan. 13, 2025 Phase 1 interim results expected for SPY002, two distinct...

      January 13 2025
      PR Newswire (US)

      Spyre Therapeutics Announces Grants of Inducement Awards

      Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass., Jan. 3, 2025 WALTHAM, Mass., Jan. 3, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the...

      January 03 2025
      PR Newswire (US)

      Spyre Therapeutics Added to the Nasdaq Biotechnology Index

      Spyre Therapeutics Added to the Nasdaq Biotechnology Index PR Newswire WALTHAM, Mass., Dec. 18, 2024 WALTHAM, Mass., Dec. 18, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a...

      December 18 2024
      PR Newswire (US)

      Spyre Therapeutics Announces Grants of Inducement Awards

      Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass., Dec. 2, 2024 WALTHAM, Mass., Dec. 2, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the...

      December 02 2024
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.79-3.4817100044122.6922.8120.2552760521.53078614CS
      4-1.7-7.2033898305123.626.0120.2557485122.26657752CS
      12-15.1-40.81081081083740.2620.2561726626.4364763CS
      26-9.15-29.468599033831.0540.2620.2553307227.73248952CS
      52-5.6-20.363636363627.547.9720.0752410929.54780438CS
      15611.09102.59019426510.8147.9710.4248001229.05034349CS
      26011.09102.59019426510.8147.9710.4248001229.05034349CS

      SYRE - Frequently Asked Questions (FAQ)

      What is the current Spyre Therapeutics share price?
      The current share price of Spyre Therapeutics is $ 21.90
      How many Spyre Therapeutics shares are in issue?
      Spyre Therapeutics has 51,431,220 shares in issue
      What is the market cap of Spyre Therapeutics?
      The market capitalisation of Spyre Therapeutics is USD 1.12B
      What is the 1 year trading range for Spyre Therapeutics share price?
      Spyre Therapeutics has traded in the range of $ 20.07 to $ 47.97 during the past year
      What is the PE ratio of Spyre Therapeutics?
      The price to earnings ratio of Spyre Therapeutics is -3.32
      What is the cash to sales ratio of Spyre Therapeutics?
      The cash to sales ratio of Spyre Therapeutics is 1.27k
      What is the reporting currency for Spyre Therapeutics?
      Spyre Therapeutics reports financial results in USD
      What is the latest annual turnover for Spyre Therapeutics?
      The latest annual turnover of Spyre Therapeutics is USD 886k
      What is the latest annual profit for Spyre Therapeutics?
      The latest annual profit of Spyre Therapeutics is USD -338.79M
      What is the registered address of Spyre Therapeutics?
      The registered address for Spyre Therapeutics is 1521 CONCORD PIKE, SUITE 201, NEW CASTLE, WILMINGTON, DELAWARE, 19803
      What is the Spyre Therapeutics website address?
      The website address for Spyre Therapeutics is www.spyre.com
      Which industry sector does Spyre Therapeutics operate in?
      Spyre Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DGNXDiginex Ltd
      $ 49.18
      (228.09%)
      		3.34M
      SLXNSilexion Therapeutics Corporation
      $ 3.1301
      (131.86%)
      		330.45M
      KRKR36Kr Holdings Inc
      $ 9.10
      (114.12%)
      		23.61M
      SPGCSacks Parente Golf Inc
      $ 0.6001
      (57.92%)
      		52.17M
      XFORX4 Pharmaceuticals Inc
      $ 0.7542
      (56.54%)
      		42.5M
      ZKINZK International Group Co Ltd
      $ 0.4813
      (-41.21%)
      		3.1M
      MGOLMGO Global Inc
      $ 0.1019
      (-38.73%)
      		70.52M
      BACKIMAC Holdings Inc
      $ 0.7869
      (-35.50%)
      		2.37M
      EYENEyenovia Inc
      $ 0.03695
      (-35.18%)
      		25.31M
      HAOHaoxi Health Technology Ltd
      $ 2.52
      (-31.89%)
      		484.94k
      NVDANVIDIA Corporation
      $ 123.70
      (-4.10%)
      		466.94M
      SLXNSilexion Therapeutics Corporation
      $ 3.1301
      (131.86%)
      		330.45M
      OCEAOcean Biomedical Inc
      $ 0.249929
      (-24.26%)
      		186.52M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.428
      (-6.98%)
      		148.12M
      RIMEAlgorhythm Holdings Inc
      $ 0.0259
      (-16.18%)
      		138.96M

      SYRE Discussion

      View Posts
      Monksdream Monksdream 5 months ago
      SYRE up and down but mostly up
      👍️0
      Monksdream Monksdream 11 months ago
      SYRE new 52=week high
      👍️0

      Your Recent History

      NASDAQ
      SYRE
      Spyre Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads